CAS 1240305-17-2

Fórmula: C37H55N3O8

InChI: InChI=1S/C37H55N3O8/c1-22(2)26-20-28(47-9)27(33-32(44)31(43)30(42)29(21-41)48-33)19-25(26)18-24-12-10-23(11-13-24)14-15-36(3,4)34(45)39-37(5,6)35(46)38-16-17-40(7)8/h10-15,19-20,22,29-33,41-44H,16-18,21H2,1-9H3,(H,38,46)(H,39,45)/b15-14+/t29-,30-,31+,32-,33+/m1/s1

Chave InChI: MUBBPBZRFJGZEU-XSPPBVGUSA-N

SMILES: CC(C)C1=CC(=C(C=C1CC2=CC=C(C=C2)/C=C/C(C)(C)C(=O)NC(C)(C)C(=O)NCCN(C)C)[C@H]3[C@@H]([C@H]([C@@H]([C@H](O3)CO)O)O)O)OC

SGL5213

CAS: 1240305-17-2

SGL5213 is a potent oral SGLT1 inhibitor (IC50: 29 nM) with potential for treating type 2 diabetes.

Fórmula: C₃₇H₅₅N₃O₈

Pureza: 98%

Cor e Forma: Solid

Peso molecular: 669.85

Ref: TM-T12892